Zewail City Partakes in BioVisionAlexandria (BVA) 2016

Zewail City of Science and Technology is participating in the eighth International Biennial Conference BioVisionAlexandria (BVA 2016), as one of the conference sponsors. The conference will take place at Bibliotheca Alexandrina, Egypt during the period from April 12 - 14, 2016.

With the theme “New Life Sciences: The Road Ahead,” the conference is going to explore new scientific frontiers and fundamental changes in life sciences as well as next generation technologies, needed to face our global hurdles and threats.

Explaining the importance of life sciences, Prof. Sherif El-Khamisy, director of the Center for Genomics at Zewail City and one of BVA’s invited speakers, said “Through life sciences researchers can harness important information that will ultimately lead to discoveries of new therapies and disease modifying strategies.” He added that the aim of these discoveries is to improve human health and consequently result in higher productivity.

With that target in mind, Zewail City has designed a biomedical sciences undergraduate and graduate program intended to foster cutting edge research and qualify students to take on major health challenges in Egypt. The city also launched Helmy Institute for Medical Sciences (HIMS) in January 2013, that study and research different topics from genomics, to stem cells, metabolism, molecular biology, and increasing the life span of Egyptians.

Joining El-Khamisy as invited speakers from Zewail City are Prof. Sameh Ali, professor of biophysics; and Prof. Nagwa El-Badri, director of the Center of Excellence for Stem Cells and Regenerative Medicine (CESC).

In her talk, El-Badri will cover the ongoing research activities at CESC, as well as the biotechnological advances in stem cell research. Similarly, Ali’s talk will focus on the Center for Aging and Associated Diseases’ recent research findings on the utilization of mesenchymal stem cells for the treatment of type II diabetes. Finally, El-khamisy will discuss how cells overcome instability, and how researchers can develop new disease modifying options and reduce the high economic burden of care in many disorders.

BVA is a unique opportunity that gathers more than 2,000 participants as well as international and national corporate representatives. The three-day conference is going to be attended by numerous Nobel laureates, distinguished keynote speakers, eminent scientists, CEOs of several national and international companies, and ministers of health and agriculture, from the four corners of the globe, all aiming to establish constructive dialogues in the areas of health, food and agriculture, industry and environment; and exchange remarkable information in the biotechnological field.